Actinogen Medical Limited Stock
Stocks
ACW
AU000000ACW3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:26 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0530 AUD | +10.42% |
|
+20.45% | -13.11% |
| 08-31 | Actinogen Medical Limited - Special Call | |
| 08-27 | Actinogen Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 197M 142M 122M 115M 105M 197M 13.42B 1.36B 527M 6.89B 533M 522M 22.18B | P/E 2027 * |
-
| P/E 2028 * | -530x |
|---|---|---|---|---|---|
| Enterprise Value | 197M 142M 122M 115M 105M 197M 13.42B 1.36B 527M 6.89B 533M 522M 22.18B | EV / Sales 2027 * |
5.12x | EV / Sales 2028 * | - |
| Free-Float |
83.36% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACW | Delayed | |
Deutsche Boerse AG
| 3AC | Delayed | |
OTC Markets
| ATGGF | Delayed |
Last Transcript : Actinogen Medical Limited
| 1 day | +10.42% | ||
| 1 week | +20.45% | ||
| Current month | +23.26% | ||
| 1 month | +23.26% | ||
| 3 months | +47.22% | ||
| 6 months | +29.27% | ||
| Current year | -13.11% |
| 1 week | 0.04 | 0.06 | |
| 1 month | 0.04 | 0.06 | |
| Current year | 0.03 | 0.07 | |
| 1 year | 0.03 | 0.07 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.2 | |
| 10 years | 0.01 | 0.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Gourlay
CEO | Chief Executive Officer | 66 | 2021-03-14 |
William Souter
DFI | Director of Finance/CFO | - | 2024-02-04 |
Dana Hilt
CTO | Chief Tech/Sci/R&D Officer | 73 | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Geoff Brooke
CHM | Chairman | 70 | 2017-02-28 |
George Morstyn
BRD | Director/Board Member | 75 | 2017-11-30 |
Malcolm McComas
BRD | Director/Board Member | 70 | 2019-04-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/28/26 | Exercice | Founder | -275,331 | 0.0074% | ||
| 8/28/26 | Exercice | Director | -307,269 | 0.0083% | ||
| 8/28/26 | Exercice | Director | 307,269 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +10.42% | +20.45% | +89.29% | +130.43% | 142M | ||
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | ||
| -2.06% | -0.18% | +39.67% | +85.24% | 64.94B | ||
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | ||
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | ||
| -3.00% | -2.90% | +33.13% | +14.91% | 25.74B | ||
| -1.46% | +0.42% | +23.61% | -16.76% | 20.09B | ||
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | ||
| -1.49% | -4.88% | -6.60% | +559.57% | 14.92B | ||
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | ||
| Average | -0.20% | +2.28% | +47.36% | +176.03% | 27.92B | |
| Weighted average by Cap. | -1.51% | +0.19% | +38.40% | +138.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 38.5M 27.75M 23.89M 22.47M 20.51M 38.38M 2.62B 265M 103M 1.34B 104M 102M 4.33B | - |
| Net income | -700K -505K -434K -409K -373K -698K -47.66M -4.83M -1.87M -24.45M -1.89M -1.85M -78.78M | -49.6M -35.75M -30.77M -28.95M -26.42M -49.45M -3.38B -342M -133M -1.73B -134M -131M -5.58B |
| Net Debt | - | - |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | A$0.0530 | +10.42% | 11,923,282 |
| 26-09-03 | A$0.0480 | +11.63% | 19,535,652 |
| 26-09-02 | A$0.0430 | +4.88% | 3,371,727 |
| 26-09-01 | A$0.0410 | -4.65% | 4,451,841 |
| 26-08-31 | A$0.0430 | -2.27% | 1,374,601 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.0530AUD
Average target price
0.0800AUD
Spread / Average Target
+50.94%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACW Stock
Select your edition
All financial news and data tailored to specific country editions

















